Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,734 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,061 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00786006 | Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer | completed | Phase 2 | 61 | Asan Medical CenterOTHER | 1 | Dec 6, 2011 | clinicaltrials |
| NCT01268384 | Neoadjuvant FDR GX in Locally Advanced Pancreatic Cancer | completed | Phase 2 | 43 | Asan Medical CenterOTHER | 1 | Dec 6, 2011 | clinicaltrials |
| NCT01175291 |
| FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer |
| withdrawn |
| Phase 2 |
| 0 |
| H. Lee Moffitt Cancer Center and Research InstituteOTHER |
| 0 |
| Dec 5, 2011 |
| clinicaltrials |
| NCT00673504 | First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 105 | Central European Society for Anticancer Drug ResearchOTHER | 2 | Dec 1, 2011 | clinicaltrials |
| NCT01155440 | Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine | completed | Phase 2 | 60 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT01477190 | Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program | completed | Phase 1 / Phase 2 | 40 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT00866944 | Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases(MT201-204) | completed | Phase 2 | 35 | Amgen Research (Munich) GmbHINDUSTRY | 2 | Nov 11, 2011 | clinicaltrials |
| NCT01349517 | Health-related Quality of Life of Patients With Esophageal Cancer After Surgery | unknown | Phase 2 | 400 | Fudan UniversityOTHER | 1 | Nov 11, 2011 | clinicaltrials |
| NCT00354978 | Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | completed | Phase 2 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT01070355 | Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases(EMT) | completed | Phase 2 | 88 | University of LeedsOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT00985556 | Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer | unknown | Phase 2 | 130 | Yonsei UniversityOTHER | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00519688 | UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma | completed | Phase 2 | 44 | National Taiwan University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00668863 | Study Of Sunitinib With FOLFIRI In Colorectal Cancer | completed | Phase 2 | 71 | PfizerINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00250822 | Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter | completed | Phase 2 | 11 | New Mexico Cancer Research AllianceOTHER | 1 | Oct 5, 2011 | clinicaltrials |
| NCT01253837 | L19TNFα in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 34 | Philogen S.p.A.INDUSTRY | 1 | Sep 23, 2011 | clinicaltrials |
| NCT00931840 | A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma | unknown | Phase 2 | 220 | Enzon Pharmaceuticals, Inc.INDUSTRY | 5 | Sep 20, 2011 | clinicaltrials |
| NCT01436721 | Use of an Oxidized Regenerated Cellulose After Hepatic Surgery | unknown | Phase 2 / Phase 3 | 40 | Fudan UniversityOTHER | 1 | Sep 20, 2011 | clinicaltrials |
| NCT00659022 | Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth | unknown | Phase 2 | 60 | Radboud University Medical CenterOTHER | 1 | Sep 12, 2011 | clinicaltrials |
| NCT00795977 | Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 20 | Fukushima Medical UniversityOTHER | 1 | Sep 8, 2011 | clinicaltrials |
| NCT01429961 | Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 38 | Seoul National University HospitalOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00145665 | The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases | terminated | Phase 1 / Phase 2 | 80 | Radboud University Medical CenterOTHER | 1 | Sep 5, 2011 | clinicaltrials |
| NCT00438737 | Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer | unknown | Phase 2 | 100 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 2, 2011 | clinicaltrials |
| NCT00703365 | Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 45 | Mahidol UniversityOTHER | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00345696 | 1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR. | completed | Phase 2 | 32 | Unidad Integral de Investigación en Oncología S.L.OTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00073736 | Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 28 | Ligand PharmaceuticalsINDUSTRY | 3 | Aug 12, 2011 | clinicaltrials |
| NCT01322178 | Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients(CLIME) | unknown | Phase 2 | 90 | Fudan UniversityOTHER | 1 | Aug 12, 2011 | clinicaltrials |
| NCT00865982 | Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer(DCXAIOCHARITE) | unknown | Phase 2 | 50 | Charite University, Berlin, GermanyOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00568646 | Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer | completed | Phase 2 | 33 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Aug 4, 2011 | clinicaltrials |
| NCT01402180 | Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy(Nimotuzumab) | unknown | Phase 2 / Phase 3 | 128 | Fudan UniversityOTHER | 1 | Jul 26, 2011 | clinicaltrials |
| NCT00004233 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | completed | Phase 2 | 65 | SWOG Cancer Research NetworkNETWORK | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00683085 | Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 2 | Tokyo UniversityOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT01391572 | A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer | unknown | Phase 2 | 300 | Fudan UniversityOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT00725400 | Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma | withdrawn | Phase 2 | 450 | American Scitech InternationalOTHER | 1 | Jul 20, 2011 | clinicaltrials |
| NCT01396668 | Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer | completed | Phase 2 | 35 | Seoul National University HospitalOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT01396681 | Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer | completed | Phase 2 | 70 | Seoul National University HospitalOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00287222 | Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma | completed | Phase 2 | 21 | University of ArkansasOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT01126866 | Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy(APRIORI) | terminated | Phase 2 | 35 | National Center for Tumor Diseases, HeidelbergOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT00882869 | XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 75 | Aegera TherapeuticsINDUSTRY | 1 | Jul 13, 2011 | clinicaltrials |
| NCT00970138 | Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 141 | Fudan UniversityOTHER | 1 | Jul 12, 2011 | clinicaltrials |
| NCT00910572 | Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma | completed | Phase 2 | 60 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00268840 | The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer | completed | Phase 2 | 45 | ARCAGY/ GINECO GROUPOTHER | 1 | Jun 30, 2011 | clinicaltrials |
| NCT01056796 | Compression Anastomosis For Low Anterior Resection in Previously Radiated Patients Using the CAR™ 27 | unknown | Phase 2 | 10 | Niti Medical Technologies Ltd.INDUSTRY | 1 | Jun 30, 2011 | clinicaltrials |
| NCT00287755 | Clinical Trial of Chemosensitivity Test | completed | Phase 2 | 300 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00497263 | End-to-End Compression Anastomosis for Left-sided Colectomy Endo-CAR Study | completed | Phase 2 | — | Niti Medical Technologies Ltd.INDUSTRY | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00514163 | GEM vs GEM+TS-1 for Advanced Pancreatic Cancer | completed | Phase 2 | 110 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00559455 | Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma | completed | Phase 2 | 38 | SanofiINDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00595972 | Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer | completed | Phase 2 | 25 | Fudan UniversityOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00639327 | Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer | completed | Phase 2 / Phase 3 | 300 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00809796 | A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment | completed | Phase 1 / Phase 2 | 15 | Oncozyme Pharma Inc.INDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
Data updated 24 days agoSource updated Dec 6, 2011source: clinicaltrials